强烈与 ROS 相关、时间依赖性和合成纳米囊泡对 BRAF 突变型黑素瘤细胞及其基于透明质酸的水凝胶制剂的选择性抗增殖作用。

Strongly ROS-Correlated, Time-Dependent, and Selective Antiproliferative Effects of Synthesized Nano Vesicles on BRAF Mutant Melanoma Cells and Their Hyaluronic Acid-Based Hydrogel Formulation.

机构信息

Department of Pharmacy, University of Genoa, Viale Cembrano, 16148 Genoa, Italy.

Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, 16147 Genoa, Italy.

出版信息

Int J Mol Sci. 2024 Sep 19;25(18):10071. doi: 10.3390/ijms251810071.

Abstract

Cutaneous metastatic melanoma (CMM) is the most aggressive form of skin cancer with a poor prognosis. Drug-induced secondary tumorigenesis and the emergency of drug resistance worsen an already worrying scenario, thus rendering urgent the development of new treatments not dealing with mutable cellular processes. Triphenyl phosphonium salts (TPPSs), in addiction to acting as cytoplasmic membrane disruptors, are reported to be mitochondria-targeting compounds, exerting anticancer effects mainly by damaging their membranes and causing depolarization, impairing mitochondria functions and their DNA, triggering oxidative stress (OS), and priming primarily apoptotic cell death. TPP-based bola amphiphiles are capable of self-forming nanoparticles (NPs) with enhanced biological properties, as commonly observed for nanomaterials. Already employed in several other biomedical applications, the per se selective potent antibacterial effects of a TPP bola amphiphile have only recently been demonstrated on 50 multidrug resistant (MDR) clinical superbugs, as well as its exceptional and selective anticancer properties on sensitive and MDR neuroblastoma cells. Here, aiming at finding new molecules possibly developable as new treatments for counteracting CMM, the effects of this TPP-based bola amphiphile (BPPB) have been investigated against two BRAF mutants CMM cell lines (MeOV and MeTRAV) with excellent results (even IC = 49 nM on MeOV after 72 h treatment). With these findings and considering the low cytotoxicity of BPPB against different mammalian non-tumoral cell lines and red blood cells (RBCs, selectivity indexes up to 299 on MeOV after 72 h treatment), the possible future development of BPPB as topical treatment for CMM lesions was presumed. With this aim, a biodegradable hyaluronic acid (HA)-based hydrogel formulation (HA-BPPB-HG) was prepared without using any potentially toxic crosslinking agents simply by dispersing suitable amounts of the two ingredients in water and sonicating under gentle heating. HA-BPPB-HA was completely characterized, with promising outcomes such as high swelling capability, high porosity, and viscous elastic rheological behavior.

摘要

皮肤转移性黑色素瘤(CMM)是最具侵袭性的皮肤癌,预后不良。药物诱导的继发性肿瘤形成和耐药性的出现,使情况更加令人担忧,因此迫切需要开发不针对可变性细胞过程的新治疗方法。三苯基膦盐(TPPSs)除了作为细胞质膜破坏剂外,还被报道为靶向线粒体的化合物,主要通过破坏其膜并导致去极化来发挥抗癌作用,从而损害线粒体功能及其 DNA,引发氧化应激(OS),并引发主要的细胞凋亡。基于 TPP 的 bola 两亲物能够自形成具有增强生物学特性的纳米颗粒(NPs),这在纳米材料中很常见。已经在其他几种生物医学应用中使用,最近才证明了一种 TPP bola 两亲物本身具有选择性的强大抗细菌作用,对 50 多种多药耐药(MDR)临床超级细菌有效,以及对敏感和 MDR 神经母细胞瘤细胞的异常和选择性抗癌作用。在这里,为了寻找可能开发为治疗皮肤转移性黑色素瘤的新分子,研究了这种基于 TPP 的 bola 两亲物(BPPB)对两种 BRAF 突变的皮肤转移性黑色素瘤细胞系(MeOV 和 MeTRAV)的影响,结果非常出色(甚至在 72 小时治疗后,MeOV 的 IC = 49 nM)。有了这些发现,并考虑到 BPPB 对不同哺乳动物非肿瘤细胞系和红细胞(RBC)的低细胞毒性(在 72 小时治疗后,MeOV 的选择性指数高达 299),可以假设 BPPB 可能作为皮肤转移性黑色素瘤病变的局部治疗药物进行开发。为此,制备了一种可生物降解的透明质酸(HA)基水凝胶制剂(HA-BPPB-HG),无需使用任何潜在有毒的交联剂,只需将两种成分适当地分散在水中,并在温和加热下超声分散即可。HA-BPPB-HA 得到了完全表征,具有高溶胀能力、高孔隙率和粘性弹性流变学行为等有前途的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41e/11432396/6f44f96c885a/ijms-25-10071-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索